These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9345266)

  • 1. GTP loading of farnesylated p21Ras by insulin at the plasma membrane.
    Goalstone M; Leitner JW; Draznin B
    Biochem Biophys Res Commun; 1997 Oct; 239(1):42-5. PubMed ID: 9345266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased amounts of farnesylated p21Ras in tissues of hyperinsulinaemic animals.
    Goalstone ML; Wall K; Leitner JW; Kurowski T; Ruderman N; Pan SJ; Ivy JL; Moller DE; Draznin B
    Diabetologia; 1999 Mar; 42(3):310-6. PubMed ID: 10096783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dominant negative farnesyltransferase alpha-subunit inhibits insulin mitogenic effects.
    Solomon CS; Goalstone ML
    Biochem Biophys Res Commun; 2001 Jul; 285(2):161-6. PubMed ID: 11444820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperinsulinemia potentiates activation of p21Ras by growth factors.
    Leitner JW; Kline T; Carel K; Goalstone M; Draznin B
    Endocrinology; 1997 May; 138(5):2211-4. PubMed ID: 9112423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin stimulates the phosphorylation and activity of farnesyltransferase via the Ras-mitogen-activated protein kinase pathway.
    Goalstone M; Carel K; Leitner JW; Draznin B
    Endocrinology; 1997 Dec; 138(12):5119-24. PubMed ID: 9389491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dominant negative alpha-subunit of FTase inhibits effects of insulin and IGF-I in MCF-7 cells.
    Solomon CS; Goalstone ML
    Biochem Biophys Res Commun; 2002 Mar; 291(3):458-65. PubMed ID: 11855811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of insulin on farnesyltransferase gene transcription and mRNA stability.
    Goalstone ML; Draznin B
    Biochem Biophys Res Commun; 1999 Jan; 254(1):243-7. PubMed ID: 9920764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of insulin on farnesyltransferase activity in 3T3-L1 adipocytes.
    Goalstone ML; Draznin B
    J Biol Chem; 1996 Nov; 271(44):27585-9. PubMed ID: 8910345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dominant negative alpha-subunit of farnesyl- and geranylgeranyl-transferase I inhibits insulin-induced differentiation of 3T3-L1 pre-adipocytes.
    Solomon CS; Leitner JW; Goalstone ML
    Int J Obes Relat Metab Disord; 2003 Jan; 27(1):40-7. PubMed ID: 12532152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of insulin on prenylation as a mechanism of potentially detrimental influence of hyperinsulinemia.
    Draznin B; Miles P; Kruszynska Y; Olefsky J; Friedman J; Golovchenko I; Stjernholm R; Wall K; Reitman M; Accili D; Cooksey R; McClain D; Goalstone M
    Endocrinology; 2000 Apr; 141(4):1310-6. PubMed ID: 10746633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against malignant conversion in SENCAR mouse skin by all trans retinoic acid: inhibition of the ras p21-processing enzyme farnesyltransferase and Ha-ras p21 membrane localization.
    Agarwal R; Mohan RR; Ahmad N; Mukhtar H
    Mol Carcinog; 1996 Sep; 17(1):13-22. PubMed ID: 8876671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of insulin on farnesyltransferase. Specificity of insulin action and potentiation of nuclear effects of insulin-like growth factor-1, epidermal growth factor, and platelet-derived growth factor.
    Goalstone ML; Leitner JW; Wall K; Dolgonos L; Rother KI; Accili D; Draznin B
    J Biol Chem; 1998 Sep; 273(37):23892-6. PubMed ID: 9727002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin and epidermal growth factor influence guanine nucleotide-releasing factor by distinct mechanisms.
    Langlois WJ; Medh J; Leitner JW; Sasaoka T; Olefsky JM; Draznin B
    Endocrinology; 1994 Dec; 135(6):2412-7. PubMed ID: 7988425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What does insulin do to Ras?
    Goalstone ML; Draznin B
    Cell Signal; 1998 May; 10(5):297-301. PubMed ID: 9692672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low molecular weight GTP-binding proteins in hepatocytes and an assessment of the role of p21ras proteins in the activation of phospholipase D.
    Hurst KM; Chataway TK; Hughes BP; Barritt GJ
    Biochem Int; 1991 Jun; 24(3):507-16. PubMed ID: 1772429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical and biological consequences of changing the specificity of p21ras from guanosine to xanthosine nucleotides.
    Schmidt G; Lenzen C; Simon I; Deuter R; Cool RH; Goody RS; Wittinghofer A
    Oncogene; 1996 Jan; 12(1):87-96. PubMed ID: 8552403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S-Acylation and plasma membrane targeting of the farnesylated carboxyl-terminal peptide of N-ras in mammalian fibroblasts.
    Schroeder H; Leventis R; Rex S; Schelhaas M; Nägele E; Waldmann H; Silvius JR
    Biochemistry; 1997 Oct; 36(42):13102-9. PubMed ID: 9335573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversion of a human tumour cell line containing oncogenic p21ras is associated with a defect in the post-translational processing of the ras protein.
    Tilbrook PA; Paterson HF; Marshall CJ
    Oncogene; 1995 Feb; 10(4):805-9. PubMed ID: 7862461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ras farnesyltransferase inhibition: a novel and safe approach for cancer chemotherapy.
    Nammi S; Lodagala DS
    Acta Pharmacol Sin; 2000 May; 21(5):396-404. PubMed ID: 11324435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged vs transient roles for early cell cycle signaling components.
    Rose DW; Xiao S; Pillay TS; Kolch W; Olefsky JM
    Oncogene; 1998 Aug; 17(7):889-99. PubMed ID: 9780005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.